UniProt ID | FES_HUMAN | |
---|---|---|
UniProt AC | P07332 | |
Protein Name | Tyrosine-protein kinase Fes/Fps | |
Gene Name | FES | |
Organism | Homo sapiens (Human). | |
Sequence Length | 822 | |
Subcellular Localization |
Cytoplasm, cytosol. Cytoplasm, cytoskeleton. Cell membrane Peripheral membrane protein Cytoplasmic side. Cytoplasmic vesicle. Golgi apparatus. Cell junction, focal adhesion. Distributed throughout the cytosol when the kinase is not activated. Assoc |
|
Protein Description | Tyrosine-protein kinase that acts downstream of cell surface receptors and plays a role in the regulation of the actin cytoskeleton, microtubule assembly, cell attachment and cell spreading. Plays a role in FCER1 (high affinity immunoglobulin epsilon receptor)-mediated signaling in mast cells. Acts down-stream of the activated FCER1 receptor and the mast/stem cell growth factor receptor KIT. Plays a role in the regulation of mast cell degranulation. Plays a role in the regulation of cell differentiation and promotes neurite outgrowth in response to NGF signaling. Plays a role in cell scattering and cell migration in response to HGF-induced activation of EZR. Phosphorylates BCR and down-regulates BCR kinase activity. Phosphorylates HCLS1/HS1, PECAM1, STAT3 and TRIM28.. | |
Protein Sequence | MGFSSELCSPQGHGVLQQMQEAELRLLEGMRKWMAQRVKSDREYAGLLHHMSLQDSGGQSRAISPDSPISQSWAEITSQTEGLSRLLRQHAEDLNSGPLSKLSLLIRERQQLRKTYSEQWQQLQQELTKTHSQDIEKLKSQYRALARDSAQAKRKYQEASKDKDRDKAKDKYVRSLWKLFAHHNRYVLGVRAAQLHHQHHHQLLLPGLLRSLQDLHEEMACILKEILQEYLEISSLVQDEVVAIHREMAAAAARIQPEAEYQGFLRQYGSAPDVPPCVTFDESLLEEGEPLEPGELQLNELTVESVQHTLTSVTDELAVATEMVFRRQEMVTQLQQELRNEEENTHPRERVQLLGKRQVLQEALQGLQVALCSQAKLQAQQELLQTKLEHLGPGEPPPVLLLQDDRHSTSSSEQEREGGRTPTLEILKSHISGIFRPKFSLPPPLQLIPEVQKPLHEQLWYHGAIPRAEVAELLVHSGDFLVRESQGKQEYVLSVLWDGLPRHFIIQSLDNLYRLEGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
64 | Phosphorylation | GGQSRAISPDSPISQ CCCCCCCCCCCCCCH | 22.97 | 28450419 | |
67 | Phosphorylation | SRAISPDSPISQSWA CCCCCCCCCCCHHHH | 27.76 | 28450419 | |
70 | Phosphorylation | ISPDSPISQSWAEIT CCCCCCCCHHHHHHH | 22.88 | 28450419 | |
72 | Phosphorylation | PDSPISQSWAEITSQ CCCCCCHHHHHHHHH | 22.82 | 28450419 | |
77 | Phosphorylation | SQSWAEITSQTEGLS CHHHHHHHHHCHHHH | 13.29 | 28450419 | |
100 | Phosphorylation | DLNSGPLSKLSLLIR HHHCCCCHHHHHHHH | 34.38 | - | |
115 | Phosphorylation | ERQQLRKTYSEQWQQ HHHHHHHHHHHHHHH | 26.33 | 19845377 | |
116 | Phosphorylation | RQQLRKTYSEQWQQL HHHHHHHHHHHHHHH | 17.16 | 19845377 | |
117 | Phosphorylation | QQLRKTYSEQWQQLQ HHHHHHHHHHHHHHH | 28.66 | 27251275 | |
149 | Phosphorylation | YRALARDSAQAKRKY HHHHHHHHHHHHHHH | 19.41 | 27251275 | |
156 | Phosphorylation | SAQAKRKYQEASKDK HHHHHHHHHHHHHCC | 18.67 | 22817900 | |
261 | Phosphorylation | RIQPEAEYQGFLRQY HHCCHHHHHHHHHHH | 22.45 | 21253578 | |
332 | Phosphorylation | FRRQEMVTQLQQELR HHHHHHHHHHHHHHH | 23.42 | 24043423 | |
373 | Phosphorylation | GLQVALCSQAKLQAQ HHHHHHHHHHHHHHH | 33.74 | - | |
408 | Phosphorylation | LLQDDRHSTSSSEQE EEECCCCCCCCHHHH | 30.77 | 23401153 | |
409 | Phosphorylation | LQDDRHSTSSSEQER EECCCCCCCCHHHHH | 26.88 | 28450419 | |
410 | Phosphorylation | QDDRHSTSSSEQERE ECCCCCCCCHHHHHC | 34.58 | 26657352 | |
411 | Phosphorylation | DDRHSTSSSEQEREG CCCCCCCCHHHHHCC | 37.67 | 26657352 | |
412 | Phosphorylation | DRHSTSSSEQEREGG CCCCCCCHHHHHCCC | 42.96 | 28450419 | |
421 | Phosphorylation | QEREGGRTPTLEILK HHHCCCCCCHHHHHH | 24.73 | 29978859 | |
423 | Phosphorylation | REGGRTPTLEILKSH HCCCCCCHHHHHHHH | 36.09 | 29978859 | |
432 | Phosphorylation | EILKSHISGIFRPKF HHHHHHHCCCCCCCC | 22.03 | 24275569 | |
440 | Phosphorylation | GIFRPKFSLPPPLQL CCCCCCCCCCCCCHH | 46.20 | 22210691 | |
461 | Phosphorylation | PLHEQLWYHGAIPRA CHHHHHHHCCCCCHH | 10.04 | 20860994 | |
477 | Phosphorylation | VAELLVHSGDFLVRE HHHHHHHCCCEEEEE | 32.36 | - | |
491 | Phosphorylation | ESQGKQEYVLSVLWD ECCCCCEEHHHHHHC | 12.28 | 24825855 | |
513 | Phosphorylation | IQSLDNLYRLEGEGF ECCHHHHHHCCCCCC | 21.29 | 23532336 | |
595 | Phosphorylation | AVKSCRETLPPDLKA EEECHHHHCCCCHHH | 25.80 | - | |
597 | Ubiquitination | KSCRETLPPDLKAKF ECHHHHCCCCHHHHH | 27.98 | 21890473 | |
597 | Ubiquitination | KSCRETLPPDLKAKF ECHHHHCCCCHHHHH | 27.98 | 21890473 | |
614 | Phosphorylation | EARILKQYSHPNIVR HHHHHHHCCCCCHHH | 13.83 | 22817900 | |
655 | Ubiquitination | LRTEGARLRVKTLLQ HCCCCHHHHHHHHHH | 7.97 | 21890473 | |
667 | Ubiquitination | LLQMVGDAAAGMEYL HHHHHHHHHHHHHHH | 8.03 | 21890473 | |
698 | Ubiquitination | VTEKNVLKISDFGMS ECCCCEEEHHHCCCC | 35.56 | - | |
700 | Phosphorylation | EKNVLKISDFGMSRE CCCEEEHHHCCCCHH | 25.87 | 29978859 | |
705 | Phosphorylation | KISDFGMSREEADGV EHHHCCCCHHHHCCE | 36.60 | 29978859 | |
713 | Phosphorylation | REEADGVYAASGGLR HHHHCCEEECCCCCC | 11.28 | 15485904 | |
716 | Phosphorylation | ADGVYAASGGLRQVP HCCEEECCCCCCCCC | 25.81 | 15485904 | |
725 | Ubiquitination | GLRQVPVKWTAPEAL CCCCCCEEECCCCHH | 32.53 | 21890473 | |
734 | Phosphorylation | TAPEALNYGRYSSES CCCCHHHCCCCCCHH | 12.11 | 27273156 | |
775 | Ubiquitination | QTREFVEKGGRLPCP HHHHHHHCCCCCCCC | 62.45 | - | |
811 | Phosphorylation | RPSFSTIYQELQSIR CCCHHHHHHHHHHHH | 8.95 | 22817900 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FES_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FES_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
BCR_HUMAN | BCR | physical | 10706130 | |
HS90A_HUMAN | HSP90AA1 | physical | 9222609 | |
HSP74_HUMAN | HSPA4 | physical | 9222609 | |
FKBP4_HUMAN | FKBP4 | physical | 9222609 | |
FKBP5_HUMAN | FKBP5 | physical | 9222609 | |
TEBP_HUMAN | PTGES3 | physical | 9222609 | |
PPID_HUMAN | PPID | physical | 9222609 | |
STAT3_HUMAN | STAT3 | physical | 9714332 | |
HSH2D_HUMAN | HSH2D | physical | 11700021 | |
BCR_HUMAN | BCR | physical | 7529874 | |
MYOME_HUMAN | PDE4DIP | physical | 21900206 | |
ZN775_HUMAN | ZNF775 | physical | 21900206 | |
ZN746_HUMAN | ZNF746 | physical | 21900206 | |
TIF1B_HUMAN | TRIM28 | physical | 16792528 | |
MDFI_HUMAN | MDFI | physical | 19060904 | |
DESP_HUMAN | DSP | physical | 25852190 | |
BCAR1_MOUSE | Bcar1 | physical | 8999909 | |
FES_HUMAN | FES | physical | 26702831 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-64; SER-67; TYR-261;SER-408; THR-409; SER-410; SER-411; SER-412; THR-421; THR-423;TYR-614; TYR-713 AND SER-716, AND MASS SPECTROMETRY. | |
"Structural coupling of SH2-kinase domains links Fes and Abl substraterecognition and kinase activation."; Filippakopoulos P., Kofler M., Hantschel O., Gish G.D., Grebien F.,Salah E., Neudecker P., Kay L.E., Turk B.E., Superti-Furga G.,Pawson T., Knapp S.; Cell 134:793-803(2008). Cited for: X-RAY CRYSTALLOGRAPHY (1.78 ANGSTROMS) OF 448-822 OF UNPHOSPHORYLATEDAPOPROTEIN AND IN COMPLEX WITH STAUROSPORINE AND A SUBSTRATE PEPTIDE,CATALYTIC ACTIVITY, ENZYME REGULATION, PHOSPHORYLATION AT TYR-713, NMRSPECTROSCOPY, AND MUTAGENESIS OF GLY-463 AND ARG-483. | |
"Bimolecular fluorescence complementation demonstrates that the c-Fesprotein-tyrosine kinase forms constitutive oligomers in livingcells."; Shaffer J.M., Hellwig S., Smithgall T.E.; Biochemistry 48:4780-4788(2009). Cited for: SUBUNIT, SUBCELLULAR LOCATION, PHOSPHORYLATION AT TYR-713,PHOSPHORYLATION BY HCK, AND DOMAIN. | |
"Spatial recruitment and activation of the Fes kinase by ezrinpromotes HGF-induced cell scattering."; Naba A., Reverdy C., Louvard D., Arpin M.; EMBO J. 27:38-50(2008). Cited for: FUNCTION IN CYTOSKELETON REORGANIZATION, INTERACTION WITH EZR,PHOSPHORYLATION AT TYR-713, AND SUBCELLULAR LOCATION. | |
"The human c-Fes tyrosine kinase binds tubulin and microtubulesthrough separate domains and promotes microtubule assembly."; Laurent C.E., Delfino F.J., Cheng H.Y., Smithgall T.E.; Mol. Cell. Biol. 24:9351-9358(2004). Cited for: FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH TUBULIN ANDMICROTUBULES, SUBCELLULAR LOCATION, PHOSPHORYLATION AT TYR-713,PHOSPHORYLATION BY HCK, AND MUTAGENESIS OF LEU-145; ARG-483 ANDLYS-590. | |
"Regulation of the human c-fes protein tyrosine kinase (p93c-fes) byits src homology 2 domain and major autophosphorylation site (Tyr-713)."; Hjermstad S.J., Peters K.L., Briggs S.D., Glazer R.I., Smithgall T.E.; Oncogene 8:2283-2292(1993). Cited for: PHOSPHORYLATION AT TYR-713, CATALYTIC ACTIVITY, AND MUTAGENESIS OFTYR-713. |